Kirill V Rosen
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jun 10, 2026
Mechanistic analysis of MLKL-driven cell survival.|Feb 20, 2025
Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cells.Peijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo
|Sep 01, 2023
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugs.Sandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu
|Aug 06, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growth.Xiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang
|Mar 17, 2021
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies.Alexi Surette, Byong Hoon Yoo, Tallal Younis
|Oct 07, 2020
Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity.Arik Drucker, Byong Hoon Yoo, Iman Aftab Khan
Pageof 2